From the Editor’s desk
Why does it matter? HPV-related anal cancer disproportionally affects men who have sex with men. Vaccination and screening are key elements of effective prevention. Researchers in Sydney prospectively investigated 525 older men (35 years, median 49 years) and found that the incidence of anal infection with high-risk (HR)-HPV was 3.3 per 100 person-years. The risk increased among people with HIV and in those reporting receptive anal intercourse.
Key message: Ongoing incidence of anal HR-HPV supports HPV vaccination for sexually active older men.
Other journal’s highlights:
Perspectives: From assisted partner notification to incident HIV infections among men using cabotegravir for PrEP read about these and more here
Prof Anna Maria Geretti
Editor in Chief
Sexually Transmitted Infections